Enoxaparin vs Fondaparinux for VTE Prophylaxis in Laparoscopic sleeve gastrectomy

Thanoun, Ahmed Nazar; Abdulkadhim, Luay Mohammed; Nazar, Mohammed

doi:10.52573/ipmj.2024.140254

	Enoxaparin vs Fondaparinux for VTE Prophylaxis in Laparoscopic sleeve gastrectomy
Iraqi Postgraduate Medical Journal
Article 8, Volume 23, Issue 4, October 2024, Pages 424-429 PDF (253.58 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2024.140254
Authors
Ahmed Nazar Thanoun^* ¹; Luay Mohammed abdulkadhim²; Mohammed Nazar³
¹Department of surgery , Mosul, iraq
²Department of surgery, babel , iraq
³Department of anasthesia, mousel ,Iraq
Abstract
Abstract Background In Laparoscopic bariatric surgeries, the chance of venous thromboembolism (VTE) rises, which can have severe consequences(1). This comparative study seeks to analyze the efficacy and safety of enoxaparin and fondaparinux, two popular anticoagulants employed to prevent VTE following bariatric surgeries. Objective The objective of this study is to compare the efficacy and safety of enoxaparin and fondaparinux for VTE prophylaxis in laparoscopic sleeve surgeries, with a focus on their impact on bleeding risk. Methods This prospective randomized trial included 100 patients undergoing laparoscopic sleeve gastrectomy and compared the effectiveness and safety of fondaparinux and enoxaparin in the prevention of venous thromboembolism (VTE). These patients were divided into two groups at random: group A received postoperative enoxaparin at a dosage of 40 mg administered subcutaneously once a day; Group B received fondaparinux at a dosage of 2.5 mg administered subcutaneously once daily. The anticoagulant regimen was continued for 10 days post-surgery for both groups, with administration beginning three hours after surgery. The study aimed to assess the incidence of VTE events and bleeding complications, with patients being followed up for 4 weeks postoperatively. Results The study found that there were no statistically significant differences in age, body mass index, comorbidity prevalence rates, venous thromboembolism detection workup, operative time, blood loss, minor drain bleeding, leakage, ICU admission, or GERD. However, Group B had higher VTE risk assessment scores, indicating an increased risk of VTE compared to Group A. Conclusion Enoxaparin and fondaparinux are viable VTE prophylaxis options following LSG surgery. Selection should consider patients' risk factors, comorbidities, and any contraindications or side effects. The study found no significant statistical differences between the two drugs' efficacy in preventing VTE for LSG surgery patients.
Keywords
Key words Venous thromboembolism,,; ,،Bariatric surgery,,; ,،Thromboprophylaxis,,; ,،Deep vein thrombosis and Enoxaparin

References
Kamachi, Hirofumi et al.. Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicenter randomized clinical trial. BJS Open, 2020;4: 804-10. Ahmed, Anwar et al. The influences of bariatric surgery on hemoglobin A1c in a sample of obese patients in Saudi Arabia. Diabetes Metabolic Syndrome and Obesity Targets and Therapy, 2018;11:271-76. Muralidharan, Ramamurthy, Thoddi et al. Clinical profile and management of patients with acute pulmonary thromboembolism – a single centre, large observational study from India. Pulmonary Circulation, 2021;11:1-9. Hakeam, A., Hakeam et al. (2020, January 1). Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study. Clinical and Applied Thrombosis/Hemostasis, 26, 107602962093119. Grünewald, Martin et al. (2021, January 1). Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry. Clinical and Applied Thrombosis/Hemostasis, 27, 107602962110165. Hillbom, Matti et al.). Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurologica Scandinavica, 2002; 27106: 84-92. Jeon, Soeun et al. Acute lower extremity arterial thrombosis after intraocular foreign body removal under general anesthesia: A case report and review of literature. World Journal of Clinical Cases, 2021;9:8232-41. Zabrocka, E., Wojtukiewicz, M. Z., & Sierko, E... Thromboprophylaxis in cancer patients in hospice. Advances in Clinical and Experimental Medicine, 2018;27:283-89. Shin, S.. Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis. Journal of Pain Research, 2018;11:3211-19. Łukaszuk, R. F., Nycz, K., Plens, K., & Undas, A... Caprini VTE computerized risk assessment improves the use of thromboprophylaxis in hospitalized patients with pulmonary disorders. Advances in Clinical and Experimental Medicine, 2021;31:261-66. Yhim, H., Lee, J. O., & Bang, S. M. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. Plos One, 2017;12: e0178214. Chen, Jianle et al. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin. Clinical and Applied Thrombosis/Hemostasis, 2019;25, 107602961984070. Akin, Sakir et al. Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II. Netherlands Heart Journal, 2015;24: 134-42. Hanninen, M., Cassagneau, R., Manlucu, J., & Yee, R... Extensive Thrombosis Following Lead Extraction: Further Justification for Routine Post-operative Anticoagulation. Indian Pacing and Electrophysiology Journal, 2014;14: 150-51.
Statistics Article View: 265 PDF Download: 98